SCHEMBL6015582

SCHEMBL6015582

COc1ccc(-c2nnc(SCc3ccccn3)[nH]2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.57
CYP2E1 P05181 3/20 0.57
CYP3A4 P08684 3/20 0.57
CYP2C8 P10632 3/20 0.57
CYP2D6 P10635 3/20 0.57
CYP2C9 P11712 3/20 0.57
CYP2B6 P20813 3/20 0.57
CYP2C19 P33261 3/20 0.57
SYK P43405 4/20 0.51
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
LMNA P02545 1/20 0.49
PDE2A O00408 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NOS3 P29474 2/20 0.45
NOS1 P29475 2/20 0.45
NOS2 P35228 2/20 0.45
CHRNA7 P36544 1/20 0.45
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015589 0.89 CYP1A2 (0.52) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015605 0.89 CYP1A2 (0.57) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL645267 0.88 RAB9A (0.63) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015602 0.87 NPC1 (0.47) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015614 0.84 PDE2A (0.39) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015609 0.83 RAB9A (0.57) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015585 0.81 NPC1 (0.53) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL14778172 0.80 CYP1A2 (0.56) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015599 0.77 CYP1A2 (0.56) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL6015595 0.76 DAO (0.38) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054526-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed